2 days What Makes Addex Therapeutics (ADXN) a New Buy Stock Zacks
Addex Therapeutics (ADXN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company’s earnings prospects. This might drive the stock higher in the near term.